Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : $3.10 B

According to Argenx 's latest financial reports the company has $3.10 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$2.19 B-6.17%
2021-12-31$2.33 B-4.25%
2020-12-31$2.44 B44.84%
2019-12-31$1.68 B127.76%
2018-12-31$0.73 B42.85%
2017-12-31$0.51 B383.99%
2016-12-31$0.10 B111.81%
2015-12-31$50.51 M-39.03%
2014-12-31$82.85 M87.05%
2013-12-31$44.29 M53.77%
2012-12-31$28.8 M-27.31%
2011-12-31$39.62 M184.43%
2010-12-31$13.93 M